The project has won the “Emerging Infectious Diseases and New Radiological, Biological and Chemical Threats” Call for Expressions of Interest... View Article
Author Archives for Adeline Chauvigné
The PhagECOLI project undertaken by Pherecydes Pharma and the CEA receives a €2 million grant from Bpifrance
19 September 2025The project has won the “Emerging Infectious Diseases and New Radiological, Biological and Chemical Threats” Call for Expressions of Interest... View Article
Vincent Procaccio – Head of the Department of Genetics at Angers University Hospital, joins KetoM+
His remarkable professional skills and personality will be a great addition to our team and a critical asset for the... View Article
Vincent Procaccio – Head of the Department of Genetics at Angers University Hospital, joins KetoM+
19 September 2025His remarkable professional skills and personality will be a great addition to our team and a critical asset for the... View Article
Pherecydes Pharma obtains ANSM approval for its PhagoDAIR program, the world’s first study in precision phage therapy
PhagoDAIR is a phase I/II clinical study with anti-Staphylococcus aureus phages in the treatment of osteoarticular infections of prostheses caused... View Article
Pherecydes Pharma obtains ANSM approval for its PhagoDAIR program, the world’s first study in precision phage therapy
19 September 2025PhagoDAIR is a phase I/II clinical study with anti-Staphylococcus aureus phages in the treatment of osteoarticular infections of prostheses caused... View Article
Valneva announces positive lot-to-lot consistency trial results for its single-shot Chikungunya vaccine candidate
Valneva, a specialty vaccine company, announced positive topline results from the lot-to-lot Phase 3 trial of its single-shot chikungunya vaccine... View Article
Valneva announces positive lot-to-lot consistency trial results for its single-shot Chikungunya vaccine candidate
19 September 2025Valneva, a specialty vaccine company, announced positive topline results from the lot-to-lot Phase 3 trial of its single-shot chikungunya vaccine... View Article
Four projects involving members of the cluster, winners of the call for research proposals “Recherche Hospitalo-Universitaire en santé” (RHU)
Four projects involving members of the cluster, winners of the call for research proposals “Recherche Hospitalo-Universitaire en santé” (RHU) Olivier... View Article
Four projects involving members of the cluster, winners of the call for research proposals “Recherche Hospitalo-Universitaire en santé” (RHU)
19 September 2025Four projects involving members of the cluster, winners of the call for research proposals “Recherche Hospitalo-Universitaire en santé” (RHU) Olivier... View Article
Valneva announces positive homologous booster data for inactivated, adjuvanted COVID-19 vaccine candidate VLA
Initial results show excellent immune response after third dose of VLA2001 administered 7 to 8 months after the second dose... View Article
Valneva announces positive homologous booster data for inactivated, adjuvanted COVID-19 vaccine candidate VLA
19 September 2025Initial results show excellent immune response after third dose of VLA2001 administered 7 to 8 months after the second dose... View Article
Pherecydes Pharma continues to strengthen its intellectual property with a first patent granted in China
Pherecydes Pharma, a biotechnology company specializing in precision phage therapy to treat resistant and/or complicated bacterial infections, announced the granting... View Article
Pherecydes Pharma continues to strengthen its intellectual property with a first patent granted in China
19 September 2025Pherecydes Pharma, a biotechnology company specializing in precision phage therapy to treat resistant and/or complicated bacterial infections, announced the granting... View Article
New member | AbolerIS Pharma
AbolerIS Pharma aims to develop novel and unique therapeutic approaches to induce immune tolerance and preserves useful immune responses in... View Article
New member | AbolerIS Pharma
19 September 2025AbolerIS Pharma aims to develop novel and unique therapeutic approaches to induce immune tolerance and preserves useful immune responses in... View Article
New member | THERADEV
THERADEV develops solutions composed of phytogenic active ingredients for the prevention of metabolic diseases. Find out more about THERADEV: www.theradev.fr
New member | THERADEV
19 September 2025THERADEV develops solutions composed of phytogenic active ingredients for the prevention of metabolic diseases. Find out more about THERADEV: www.theradev.fr
New member | Theradev
Theradev specialises in the research and development of innovative solutions for the regulation of major metabolic disorders. Thanks to its... View Article
New member | Theradev
19 September 2025Theradev specialises in the research and development of innovative solutions for the regulation of major metabolic disorders. Thanks to its... View Article